info

Yes No
Moodys.com
Please Note
We brought you to this page based on your search query. If this isn't what you are looking for, you can continue to Search Results for ""
The maximum number of items you can export is 3,000. Please reduce your list by using the filtering tool to the left.
Close
Moody’s Talks - Behind the Bonds

Refine by:

JULY 2022
Pharmaceuticals earnings growth to slow; the patent cliff could spur M&A
July 19th 2022 (16.46 mins)
Frederic Duranson of the corporates team explains why pharmaceutical sector earnings growth will slow over the next 12-18 months. And Michael Levesque talks about the challenge big pharma companies face as patents on blockbuster drugs expire, and why we expect that to spur M&A.
Moodys.com